| Retail: $15Approved for 0.75 CE Credit
This article describes how PET/CT allows for in vivo and quantitative analysis of the functional status of non–small-cell lung cancer at the molecular level. In addition, the advantages of new PET tracers beyond FDG in non–small-cell lung cancer imaging are discussed, and how personalized molecular therapy will change diagnosis and treatment of this condition in the future.
The Clinics are scholarly articles licensed from Elsevier to provide additional technical content for ASRT members.
This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat a self-learning activity for credit if it was reported in the same biennium.
Free access is included with membership. All titles for which you have not previously earned CE credit appear in your CE library.
Not a member? Call Member Services to join 800-444-2778
